PMS2 and colorectal cancer: Therefore, in the medical care for colorectal cancer, if the dMMR-testing result shows MSI-H or the loss of MLH1/PMS2 expression, checking for the BRAF V600E mutation helps distinguish Lynch-associated colorectal cancers from sporadic ones [59].